Yarvie: Ledger

Stories naming Yarvie. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
Yarvie is not recorded as having acquired anything.

Name	Role	Sources
Charlotte Casebourne Stock	Executive Partner	Brandon BioCatalyst, insightnews.com.au, cera.org.au, mirugen.com

2 deals

Mirugen Secures A$4.5m to Pioneer Cell (Re)programming, and Welcomes Charlotte Casebourne Stock as Executive Chair

Mirugen, a Melbourne biotech spun out of an eye research institute, has closed a A$4.5m seed round with three backers and hired Charlotte Casebourne Stock as chair and acting chief executive.

mirugen.com 13 Aug 2025 Mirugen Theolytics Brandon BioCatalyst Centre for Eye Research Australia CSIRO CUREator Medical Research Future Fund Tanarra Capital Yarvie Brandon Capital Breakthrough Victoria Tin Alley Ventures University of Melbourne University of Melbourne Genesis Pre-Seed Fund Associate Professor Raymond Wong Charlotte Casebourne Stock Professor Keith Martin Dr Winnie Gao

Also cera.org.au·Brandon BioCatalyst portfolio·insightnews.com.au

Yarvie

Funding history

Investors

What Yarvie bought

People

Coverage

Mirugen Secures A$4.5m to Pioneer Cell (Re)programming, and Welcomes Charlotte Casebourne Stock as Executive Chair